Yayın:
In Vitro and In Silico Studies on the Toxic Effects of Antibacterial Drugs as Human Serum Paraoxonase 1 Inhibitor

dc.contributor.authorBEYDEMİR, ŞÜKRÜ
dc.contributor.authorŞükrü Beydemir
dc.contributor.authorÖmer İrfan Küfrevioğlu
dc.contributor.orcid0000-0002-2932-2789
dc.contributor.orcid0000-0003-3667-6902
dc.contributor.orcid0000-0002-1877-3154
dc.date.accessioned2025-11-13T09:29:09Z
dc.date.issued2019-09-03
dc.identifier.doihttps://doi.org/10.1002/slct.201902424
dc.identifier.endpage9736
dc.identifier.issn2365-6549
dc.identifier.issue33
dc.identifier.openalexW2972009872
dc.identifier.startpage9731
dc.identifier.urihttps://hdl.handle.net/11421/1286
dc.identifier.urihttps://doi.org/10.1002/slct.201902424
dc.identifier.volume4
dc.language.isoen
dc.relation.ispartofChemistrySelect
dc.rightsrestrictedAccess
dc.subjectChemistry
dc.subjectLinezolid
dc.subjectIn silico
dc.subjectPharmacology
dc.subjectCiprofloxacin
dc.subjectPON1
dc.subjectParaoxonase
dc.subjectAntibacterial activity
dc.subjectChromatography
dc.subjectEnzyme
dc.subjectAntibiotics
dc.subjectBiochemistry
dc.subjectBacteria
dc.subjectStaphylococcus aureus
dc.subjectBiology
dc.subjectVancomycin
dc.titleIn Vitro and In Silico Studies on the Toxic Effects of Antibacterial Drugs as Human Serum Paraoxonase 1 Inhibitor
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5081967794

Dosyalar

Koleksiyonlar